These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38280268)

  • 1. Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil.
    de Almeida GMR; de Araujo RS; Castrillo BB; Silva GD; Fortini I; Gonçalves MRR; Castro LHM; Tatsui NH; Adoni T; Sato DK; Apóstolos-Pereira SL; Callegaro D
    J Neuroimmunol; 2024 Mar; 388():578295. PubMed ID: 38280268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.
    Gonzalez C; Vargas D; Contreras K; Garcia P; Rodriguez P; Zarco L; Navas C
    Ther Apher Dial; 2022 Dec; 26(6):1274-1280. PubMed ID: 35353437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource-Limited Settings: Outcomes in a Multiethnic Single-Center Population.
    Ong ZM; Schee JP; Viswanathan S
    Ther Apher Dial; 2020 Jun; 24(3):312-323. PubMed ID: 31654607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder.
    Viswanathan S; Schee JP; Omar MA; Hiew FL
    Ther Apher Dial; 2021 Aug; 25(4):513-532. PubMed ID: 33029928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders-Experience from Tertiary Care Center in North India.
    Hans R; Prakash S; Sharma RR; Sankhyan N; Takkar A; Goyal M; Saikia B; Lal V; Marwaha N
    Neurol India; 2022; 70(2):710-713. PubMed ID: 35532644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.
    Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC
    J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
    Siritho S; Nopsopon T; Pongpirul K
    J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
    Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
    Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
    Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
    J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of the neuromyelitis optica spectrum disorder in Latin America.
    Rivera VM; Hamuy F; Rivas V; Gracia F; Rojas JI; Bichuetti DB; Villa AM; Marques VD; Soto A; Bertado B; Frenk IT; Galleguillos L; Quiñones J; Ramirez DA; Caparó-Zamalloa C; Ciampi E; Lana-Peixoto MA; Rodríguez E; Zarco L; Sinay V; Armas E; Becker J; Benzadón A; Lopez E; Carnero Contentti E; Correa-Diaz EP; Diaz A; Fleitas CV; Playas G; Molina O; Rojas E; Sato D; Soto I; Céspedes JV; Correale J; Barboza A; Monterrey P; Candelario A; Tavolini DR; Parajeles A; Pujol BS; Diaz de la Fe A; Alonso R; Bolaña C; Guzman MK; Carrá A; Gamarra OG; Raggio JV; Rodriguez LC; Ramirez NE; Ordoñez L; Skromne E; Portillo LL; Canabal AP; Weiser R; Sirias V; Calderón RF; Cornejo EA; Hernández M; Quiroz JCD; Garcia LA; Cedeño CO; Martínez J; Abad-Herrera P
    Mult Scler Relat Disord; 2021 Aug; 53():103083. PubMed ID: 34171682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
    Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
    Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.
    Demuth S; Guillaume M; Bourre B; Ciron J; Zephir H; Sirejacob Y; Kerbrat A; Lebrun-Frenay C; Papeix C; Michel L; Laplaud D; Vukusic S; Maillart E; Cohen M; Audoin B; Marignier R; Collongues N;
    J Neuroinflammation; 2022 Mar; 19(1):62. PubMed ID: 35236386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-Related Attack in Neuromyelitis Optica Spectrum Disorder With AQP4-IgG: A Single-Center Study and Meta-Analysis.
    Deng S; Lei Q; Lu W
    Front Immunol; 2021; 12():800666. PubMed ID: 35069584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein spectrum changes in exosomes after therapeutic plasma exchange in patients with neuromyelitis optica.
    Ma C; Wang S; Wang G; Wu Y; Yang T; Shen W; Zhuang Y; Zhang L; Liu X; Yang L; Feng Y; Yu Y; Liu Z; Wang D
    J Clin Apher; 2020 Jun; 35(3):206-216. PubMed ID: 32240559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
    Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H;
    Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil.
    Fukuda TG; Silva ITF; Dos Santos TSS; Filho MBP; de Abreu FF; Oliveira-Filho J
    BMC Neurol; 2022 Mar; 22(1):95. PubMed ID: 35296261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.
    Palace J; Lin DY; Zeng D; Majed M; Elsone L; Hamid S; Messina S; Misu T; Sagen J; Whittam D; Takai Y; Leite MI; Weinshenker B; Cabre P; Jacob A; Nakashima I; Fujihara K; Pittock SJ
    Brain; 2019 May; 142(5):1310-1323. PubMed ID: 30938427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.